Due to the known antiviral activity of IFNβ, constituting the first line of defence against viral infections, IFNβ-regulated miRNAs could be used as early biomarkers of COVID-19 disease, being detected before the traditional markers of immune activation or inflammation. This evidence concerns the gene IFNB1 and viral infectious disease.